Metabolomic markers of physical activity and associations with breast cancer
The IDATA study used gold standard methods to assess physical activity and also collected metabolite concentrations in participants4. The PLCO has previously measured serum metabolites in a nested case control breast cancer study3. This provides a unique opportunity to investigate the relationships of metabolomic markers of physical activity with breast cancer risk.
We anticipate that the proposed analysis will lead to the discovery of novel biomarkers of physical activity and improve our understanding the biological mechanisms underpinning the physical activity and breast cancer relationship.
Methods
Metabolites associated with physical activity will be identified using the IDATA Study (Metabolon platform).
In PLCO, serum metabolites were measured by the Metabolon platform (N postmenopausal breast cancer cases=621, N controls=621)3. For each of the physical activity associated metabolites, we will investigate associations with risk of breast cancer using conditional logistic regression, conditioned on the matching factors. All models will be adjusted for age, sex, racial/ethnic group, body mass index and detailed smoking history.
References
1. Moore SC, Lee I-M, Weiderpass E, et al. Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults. JAMA Internal Medicine. 2016;176(6):816-825. doi:10.1001/jamainternmed.2016.1548
2. Kelly RS, Kelly MP, Kelly P. Metabolomics, physical activity, exercise and health: A review of the current evidence. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2020/12/01/ 2020;1866(12):165936. doi:https://doi.org/10.1016/j.bbadis.2020.165936
3. Moore SC, Playdon MC, Sampson JN, et al. A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk. J Natl Cancer Inst. Jun 1 2018;110(6):588-597. doi:10.1093/jnci/djx244
4. Matthews CE, Kozey Keadle S, Moore SC, et al. Measurement of Active and Sedentary Behavior in Context of Large Epidemiologic Studies. Med Sci Sports Exerc. Feb 2018;50(2):266-276. doi:10.1249/mss.0000000000001428
• Investigate associations of metabolomic markers of physical activity with breast cancer risk.
Joshua Freeman: Division of Cancer Epidemiology and Genetics, NCI, MD, USA
Grace Hong: Division of Cancer Epidemiology and Genetics, NCI, MD, USA
Erikka Loftfield: Division of Cancer Epidemiology and Genetics, NCI, MD, USA
Charles Matthews: Division of Cancer Epidemiology and Genetics, NCI, MD, USA
Steven Moore: Division of Cancer Epidemiology and Genetics, NCI, MD, USA
Pedro Saint-Maurice: Division of Cancer Epidemiology and Genetics, NCI, MD, USA
-
A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk.
Moore SC, Playdon MC, Sampson JN, Hoover RN, Trabert B, Matthews CE, Ziegler RG
J. Natl. Cancer Inst. 2018 Jun; Volume 110 (Issue 6): Pages 588-597 PUBMED